Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 3Phase 2/3 2Phase 1/2 1Phase 1 1

Status

Completed 16Unknown 10Recruiting 6Terminated 3Active not recruiting 3Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 2Pancreatic Neoplasms 1Neoplasm Metastasis 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Terminated × S 1 (combination) × Clear all
NCT02867839 2024-12-03

RESCUE-GC

Peking University Cancer Hospital & Institute

Phase 3 Terminated
29 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01285557 2024-09-19

DIGEST

Taiho Oncology, Inc.

Phase 3 Terminated
361 enrolled 18 charts
Gastrointestinal

Stomach Neoplasms

NCT00602745 2016-05-26

S-1 Pancreas

Sanofi

Phase 3 Terminated
61 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡